In 2023, articles about Ozempic as the latest celebrity weight-loss miracle flooded our feeds. At first, we didn’t think much of it. Another health craze, another fleeting trend. But then came the science. Studies showed significant weight loss, reduced risk of heart attacks and diabetes, and even potential benefits for kidney disease and addiction treatment. That’s when we at Eat Well Global started paying attention. Then we started to see insights from GLP-1 medication users and healthcare professionals, from our our own research and others, all pointing to a fundamental shift in eating behaviors, lifestyle choices, and, inevitably, the food and beverage industry itself.
Read